The prion protein (PrP) is a glycosylphosphatidylinositolanchored membrane glycoprotein that plays a vital role in prion diseases, a class of fatal neurodegenerative disorders of humans and animals. Approximately 20% of human prion diseases display autosomal dominant inheritance and are linked to mutations in the PrP gene on chromosome 20. PrP mutations are thought to favor the conformational conversion of PrP into a misfolded isoform that causes disease by an unknown mechanism. The PrP mutation D178N/Met-129 is linked to fatal familial insomnia, which causes severe sleep abnormalities and autonomic dysfunction. We showed by immunoelectron microscopy that this mutant PrP accumulates abnormally in the endoplasmic reticulum and Golgi of transfected neuroblastoma N2a cells. To investigate the impact of intracellular PrP accumulation on cellular homeostasis, we did a two-dimensional gel-based differential proteomics analysis. We used wide range immobilized pH gradient strips, pH 4 -7 and 6 -11, to analyze a large number of proteins. We found changes in proteins involved in energy metabolism, redox regulation, and vesicular transport. Rab GDP dissociation inhibitor ␣ (GDI) was one of the proteins that changed most. GDI regulates vesicular protein trafficking by acting on the activity of several Rab proteins. We found a specific reduction in the level of functional Rab11 in mutant PrP-expressing cells associated with impaired post-Golgi trafficking. Our data are consistent with a model by which mutant PrP induces overexpression of GDI, activating a cytotoxic feedback loop that leads to protein accumulation in the secretory pathway. Molecular & Cellular Proteomics 9:611-622, 2010.
Familial Creutzfeldt-Jakob disease (fCJD), 1 GerstmannSträ ussler-Scheinker syndrome, and fatal familial insomnia (FFI) are dominantly inherited degenerative disorders of the central nervous system (CNS) linked to mutations in the prion protein (PrP) gene on chromosome 20 (1) . The pathogenic mutations favor conversion of PrP into a misfolded pathogenic isoform that accumulates in the CNS, ultimately leading to neuronal dysfunction and degeneration by a mechanism still unknown (2) . A mutation at PrP codon 178, resulting in the substitution of aspartic acid for asparagine is linked to two different inherited prion diseases, depending on the amino acid specified at the polymorphic site 129 of the mutant allele where either methionine or valine can be present. The D178N/ Val-129 haplotype is linked to fCJD, whereas D178N/Met-129 is associated with FFI (3).
PrP is a glycosylphosphatidylinositol (GPI)-anchored glycoprotein of uncertain function (4) . Like other membrane proteins, PrP is synthesized in the rough endoplasmic reticulum (ER), transits the Golgi, and is delivered to the cell surface where it resides in lipid rafts (5, 6) . Several mutant PrP molecules, in contrast, misfold soon after synthesis in the ER (7), accumulate in the secretory pathway, and are less efficiently delivered to the cell surface (8 -15) . Mutant PrPs expressed in transfected cells and primary neurons from transgenic mice acquire biochemical properties of pathogenic PrP, including insolubility in non-denaturing detergents and protease resistance (14, 16 -19) .
These observations suggest that mutant PrP misfolding and abnormal intracellular localization may trigger pathogenic processes (2, 20) . In line with this view, ER accumulation of mutant PrP and alteration of ER morphology have been found in the CNS of a transgenic mouse model of fCJD (15) . However, further studies are needed to decipher the cellular and molecular pathways activated by mutant PrPs that ultimately result in neuronal dysfunction and degeneration.
To investigate the impact of mutant PrP on neuronal homeostasis, we carried out a proteomics analysis of mouse neuroblastoma N2a cells expressing either wild-type (WT) PrP or the mouse homologue of the human D178N/Met-129 mutation linked to FFI (referred to as D177N/Met-128 PrP). N2a cells have been extensively used as a model system to study the cellular biology of prion disease (21, 22) . Proteomics data indicated changes in proteins involved in energy metabolism, redox regulation, and vesicular transport, including significant up-regulation of the Rab GDP dissociation inhibitor ␣ (GDI). GDI regulates the function of several Rab proteins, which are key regulators of intracellular vesicular trafficking (23, 24) . Rabs are small GTPases found solely in specific membrane compartments that function as molecular switches, cycling from an inactive, cytosolic GDP-bound state to an active membrane-associated, GTP-bound state. Excess GDI induces dissociation of GDP-bound Rabs from membranes, inhibiting vesicular transport and recycling (25) (26) (27) . We therefore investigated how GDI overexpression induced by mutant PrP affected intracellular trafficking.
EXPERIMENTAL PROCEDURES
Cells-Generation of N2a cells expressing WT or D177N/Met-128 mouse PrP carrying the epitope tag for the monoclonal antibody 3F4 has been described (14) . N2a cells were grown in Dulbecco's modified Eagle's medium and modified Eagle's medium ␣ 1:1 supplemented with 10% fetal bovine serum (Invitrogen), non-essential amino acids, and penicillin/streptomycin (Sigma) and maintained in an atmosphere of 5% CO 2 , 95% air.
Plasmids-pcDNA 3.1 plasmids encoding WT and D177N/Met-128 PrPs containing the 3F4 epitope tag have been previously described (14) . The WT and D177N PrP-EGFP constructs were generated by inserting a monomerized version of enhanced green fluorescent protein (EGFP), containing a GS linker (GGGGS, repeated four times) at its 3Ј-end, after codon 34 of mouse PrP. The plasmid carrying the GPI-anchored green fluorescent protein (GFP-GPI) cDNA (28) was kindly provided by Chiara Zurzolo (Pasteur Institute, Paris, France).
Protein Extraction-Confluent cells were scraped into ice-cold buffer containing 250 mM sucrose and 10 mM Tris-Cl, pH 7.4 and lysed in ice-cold lysis buffer containing 0.5% sodium deoxycholate, 0.5% Zwittergent, 10 mM Tris, pH 7.5, and protease inhibitors (1 g/ml pepstatin and leupeptin, 0.5 mM PMSF, 2 mM EDTA, and 80 M Z-Leu-Leu-Leu-al also called MG132 (Sigma-Aldrich)). Lysates were further disrupted by 10 passages through a 26-gauge needle, and protein concentration was determined by bicinchoninic acid (BCA) assay (Pierce).
Two-dimensional Gel Electrophoresis (2DE)-For analysis of acidic proteins, protein extracts corresponding to 0.8 mg were precipitated with a clean-up kit (GE Healthcare) and then dissolved in DeStreak TM rehydration solution (GE Healthcare) with 2% DTT and 2% carrier ampholytes, pH 4 -7. For analysis of basic proteins, 80 g of protein extracts were precipitated by adding chloroform/methanol/water (1: 4:3). The protein fraction was redissolved in 8 M urea, 2 M thiourea, and 2% CHAPS; dialyzed against a solution containing 8 M urea using a minidialysis kit (GE Healthcare); and then diluted in DeStreak rehydration solution containing 4% DTT and 4% carrier ampholytes, pH 6 -11. IEF was done using linear IPG strips (GE Healthcare) at different pH ranges: pH 4 -7, 13 cm long for separation of acidic proteins, and pH 6 -11, 7 cm long for basic proteins. IPG strips were run in an IPGphor system (GE Healthcare). Two different IEF protocols were used for acidic and basic proteins: a total of 65 kV-h (1 h at 500 V, 1 h at 1500 V, and 3 h of ramping scale to 8000 V followed by 8000 V for 7 h) for the separation of acidic proteins and a total of 47 kV-h (0.5 h at 200 V, 0.5 h at 500 V, 0.5 h at 1000 V, 1.5 h of a linear gradient to 3500 V, 2 h at 3500 V, and 2.5 h of a linear gradient to 8000 V followed by 8000 V for 4 h) for the separation of basic proteins. For the second dimension, pH 4 -7 IPG strips were run on 7.5-17.5% polyacrylamide-SDS gels. Proteins were stained using Gel-Code Blue Coomassie stain (Pierce). The pH 6 -11 IPG strips were run on a precast 4 -12% Bis-Tris-acrylamide gradient gel (Invitrogen). Proteins were visualized by SYPRO Ruby staining (Invitrogen).
Image Analysis and Statistics-Triplicates of 2D maps were obtained for the acidic and the basic proteins. Gel images were digitized with a 1680 Pro scanner (Epson) at 16-bit and 300-dpi resolution. Quantitative densitometry was carried out using Progenesis PG240 v2006 software (Nonlinear Dynamics). Detection, warping, and matching of the protein spots were done using the Combined warp and match algorithm, which uses a non-parametric pattern recognition clustering technique to align different gel images. The Total spot volumes normalization algorithm was used to calculate each protein spot volume as the sum of the intensities of the pixels within the spot's boundary minus the background level within that same boundary normalized to the total spot volumes in the gel (29) . Observed pI and M r were calculated by the software on the basis of protein spots of known characteristics. To detect differentially expressed proteins, two proteomics analyses were done, each based on a different cell clone. Only protein spots with a statistically significant change (p Ͻ 0.05 by Student's t test) of at least 1.4-fold in both analyses were further identified by mass spectrometry.
In-gel Digestion of Protein Spots-Protein spots were excised using an EX-Quest spot cutter (Bio-Rad); destained for 2 h in a solution containing 25 mM ammonium bicarbonate, 40% ethanol; and then washed with sequentially increasing percentages of acetonitrile. Proteins were in-gel digested overnight at 37°C with trypsin (Promega) at a concentration of 10 ng/l in a solution of 25 mM ammonium bicarbonate and 10% acetonitrile.
MALDI-TOF MS-Peptide mass fingerprinting was done on a Bruker Reflex III MALDI-TOF mass spectrometer equipped with a SCOUT 384 multiprobe inlet and a 337 nm nitrogen laser using ␣-cyano-4-hydroxycinnamic acid (Bruker Daltonics) as the matrix, prepared as described (30) . Tryptic digests were concentrated and desalted using ZipTip pipette tips with C 18 resin and a 0.2-l bed volume (Millipore). Aliquots of tryptic digests were mixed with 2:1 matrix solution and directly deposited on the target. All mass spectra were obtained in positive reflector mode with a delayed extraction of 200 ns. The reflector voltage was set to 23 kV, and the detector voltage was set to 1.7 kV. All the other parameters were set for optimized mass resolution. To avoid detector saturation, low mass material (500 Da) was deflected. The mass spectra were internally calibrated with trypsin autolysis fragments (842.51, 1045.56, 2211.10, and 2283.18 m/z). The mass spectra were obtained by averaging 150 -350 individual laser shots and then automatically processed by the FlexAnalysis software, version 2.0, using the following parameters: the Savitzky-Golay smoothing algorithm and the SNAP peak detection algorithm. Spectra originating from parallel protein digestions were compared pairwise to discard common peaks derived from trypsin autodigestion or from contamination with keratins. Data searches (Swiss-Prot) were done using the MASCOT software package available on the internet (Matrix Science), allowing up to one missed trypsin cleavage, carbamidomethylation of Cys and oxidation of Met as variable modifications, and a mass tolerance of Ϯ0.1 Da. In the MASCOT program, probability-based molecular weight search (MOWSE) scores (31) greater than 55 were considered significant membranes were incubated for 1 h at room temperature with a blocking buffer (5% milk in Tris-buffered saline containing 0.1% Tween 20) and probed with the primary antibody diluted in the same solution overnight at 4°C. Primary antibodies were as follows: monoclonal anti-PrP 3F4 (1:5000) (32), polyclonal anti-transposon-associated protein (TRAP) (1:5000) from Upstate, polyclonal anti-GDI (1: 2500) from Zymed Laboratories Inc., monoclonal anti-Rab11 (1:2000) from Upstate, anti-monoclonal ATPase ␣ (1:1000), polyclonal anti-AHSA1 (1:1000), monoclonal anti-annexin A2 (1:1000) from Santa Cruz Biotechnology, polyclonal anti-Rab5 (1:2000) kindly provided by Marino Zerial (Max Planck Institute, Dresden, Germany), and polyclonal anti-ERp19 (1:1000) (33) kindly provided by Marek Michalak (University of Alberta, Edmonton, Alberta, Canada). The blots were probed with goat anti-rabbit or anti-mouse peroxidase-conjugated secondary antibodies (Santa Cruz Biotechnology) and developed by the ECL protein detection system (GE Healthcare). Densitometry was done with Progenesis PG240 software. Immunoreactivity was normalized to the actual amount of proteins loaded onto the membrane as detected after Coomassie Blue or red Ponceau staining (Fluka).
Subcellular Fractionation-Cell pellets were resuspended in homogenization buffer (10 mM Tris, pH 7.4, 0.1 M NaCl, and 0.01 M EDTA) and homogenized using a Teflon/glass apparatus. Lysates
FIG. 2. Experimental design of proteomics analysis.
Two separate experiments (1 and 2) were done using two pairs of N2a clones (WT 1 , WT 2 , D177N 1 , and D177N 2 ). Image analysis of 2D map triplicates was done separately for each experiment. Acidic (pI 4 -7) and basic (pI 6 -11) proteins from WT cells and D177N cells were compared. 117 and 202 spots, respectively, were significantly different in experiments 1 and 2. 42 spots were different in both experiments and were identified (see Table I ).
FIG. 3. 2D maps showing spots with significantly different volumes.
Representative 2D gels of acidic (pI 4 -7) and basic (pI 6 -11) proteins from N2a cells expressing WT and D177N PrP are shown. Proteins in the gels were stained with Coomassie Blue (A) or SYPRO Ruby (B), digitized, and analyzed by quantitative computer-assisted densitometry. Proteins whose levels were significantly different are numbered from 1 to 20 (acidic proteins) (A) and from 21 to 42 (basic proteins) (B) ( Table I) . (35) . Electron microscopy (EM) images were acquired from thin sections using a Philips Tecnai 12 electron microscope equipped with an Ultra View CCD digital camera (Philips). Gold particles were quantified in the different compartments of the secretory pathway, and total cell, ER, and Golgi volumes were analyzed using analySIS software (Soft Imaging Systems GmbH).
Total Internal Reflection Fluorescence (TIRF) Microscopy-N2a cells stably expressing WT or D177N/Met-128 PrP were seeded on -Dishes (Ibidi, Martinsried, Germany) and transiently transfected with a plasmid carrying the GFP-GPI cDNA (28) using Lipofectamine TM 2000 (Invitrogen) according to the manufacturer's instructions. The day after transfection, cells expressing similar levels of GFP-GPI were analyzed by TIRF microscopy. In some experiments, N2a cells were seeded on -Dishes and were transiently co-transfected with 250 ng of plasmid carrying the WT or D177N/Met-128 PrP-EGFP cDNA and/or with Stealth TM small interfering RNA (siRNA) duplexes using Lipofectamine RNAiMAX (Invitrogen).
Images were acquired with an objective-based Olympus (Tokyo, Japan) TIRF illumination arm attached to an IX81 inverted microscope using a 1.45 numerical aperture 60ϫ oil immersion lens. For GFP imaging, excitation was from the 488 nm line of a 200-milliwatt argon ion laser at ϳ5% power. Specialized U-MF2 filters were from Olympus. Images were acquired using Cell M software (Olympus) and an Orca camera (Hamamatsu, Hamamatsu City, Japan). For wide field images, the laser was tuned to be focused straight through the sample. Live cells were maintained at 37°C with 5% CO 2 using a Solent Scientific Ltd. incubator (Segensworth, UK). Trafficking of GFP-GPI or PrP-EGFP fusion molecules close to the plasma membrane was measured using the track particles module of Imaris software (Bitplane, Zurich, Switzerland). Fluorescent spots were visualized and automatically detected by segmentation, and the motion path of a single spot was evaluated at consecutive time points (60 s). The total number of spots detected in 60 s was normalized to the surface area analyzed.
siRNA-siRNA duplex oligonucleotides targeting PrP and a scrambled duplex were kindly provided by Giovanna Mallucci (Medical Research Council Toxicology Unit, Leicester, UK) and used as described (36) . To knock down GDI expression, a set of three Stealth RNAi siRNAs was purchased from Invitrogen. For siRNA experiments, N2a cells were treated at ϳ30% confluency with 25 nM siRNA against GDI or with Stealth RNAi Negative Control Duplexes (Invitrogen) with matching GC content using Lipofectamine RNAiMAX (Invitrogen) as the transfection reagent according to the manufacturer's instructions. Forty-eight hours after transfection, protein extracts were analyzed for protein knockdown efficiency by slot blot analysis as described (37) .
RESULTS

D177N/Met-128 PrP Is Retained in ER and
Golgi-In primary neurons and non-neuronal cell lines, PrP molecules carrying pathogenic mutations start aggregating soon after biosynthesis in the ER and accumulate in intracellular organelles (7, 14, 15) . Consistent with previous observations (14) , D177N/Met-128 PrP expressed in N2a cells acquired distinctive biochemical characteristics of pathogenic PrP, such as insolubility in non-denaturing detergents (supplemental Fig. 1A) . We used immuno-EM to characterize the intracellular localization of mutant PrP in N2a cells in detail. Although ϳ85% of WT PrP localized on the cell surface, only ϳ25% of D177N/Met-128 PrP resided on the plasma membrane with the rest distributed between endosomes (ϳ5%), the ER (ϳ30%), and the Golgi complex (ϳ40%) (Fig. 1) . Because WT and mutant PrP were expressed at similar levels as indicated by WB (supplemental Fig. 1B) , which expressed PrP at similar levels (supplemental Fig. 1B) .
Two independent proteomics experiments were done (Fig.  2) . 2D map triplicates were obtained for each different N2a cell clone. We used two wide range immobilized pH gradient strips (pH 4 -7 and 6 -11) to resolve a large number of proteins accurately (ϳ1400 spots). Two optimized protocols were used to prepare and separate acidic and basic proteins. Optimal IEF in the alkaline region remains challenging in 2DE. Focusing basic proteins was successful only after the introduction of a dialysis step in the sample preparation and limited sample loading in the 7-cm strip (80 g). The 2DE map image analysis detected 117 and 202 spots, respectively, with significantly different volumes in the first and second experiment (Fig. 2) . We decided to further analyze only the protein spots that were significantly over-or under-represented in both experiments, changing more than 1.4-fold ( Fig. 3 and Table I ). Of these, 23 were over-and 19 were under-represented in D177N/Met-128 cells compared with WT controls. The corresponding proteins were identified by MALDI-TOF mass spectrometry (Table I ). The alteration of ATPase ␣, AHSA1, annexin A2, ERp19, and GDI was also confirmed by WB (see Fig. 5B and supplemental Fig. 2) . To reconstruct the pathways altered by mutant PrP, identified proteins were classified on the basis of gene ontology annotations provided by Protein Knowledgebase (UniProtKB). Supplemental Table  1 reports the gene ontology terms for the general biological processes associated with the identified proteins, including their up-or down-regulation. In view of the multifunctionality of the proteins, some of them were associated with multiple biological processes. The functional annotations most enriched were linked to energy metabolism, redox regulation, and protein transport (Fig. 4) . The altered proteins associated with energy metabolism were mainly in the mitochondrion, whereas the ones associated with stress response, protein folding, and redox regulation were mainly ER-associated (supplemental Table 1 ). GDI, which belongs to the protein transport functional block and is involved in vesicular protein trafficking, was one of the proteins that changed most in both experiments (3.8-fold in experiment 1 and 2.3-fold in experiment 2) (Fig. 5A) . The level of GDI reverted to normal after siRNA-mediated D177N/Val-128 PrP silencing ( Fig. 5C and supplemental Fig. 3 ), confirming that mutant PrP was directly responsible for the GDI increase. We then decided to investigate any functional changes associated with GDI overexpression.
GDI Overexpression in Mutant Cells Is Associated with Reduced Levels of Membrane-associated Rab11-GDI controls protein trafficking by regulating the function of Rab proteins.
Rabs are functionally active when located on membranes in the GTP-bound state but are inactive when associated with GDI in the cytoplasm in the GDP-bound state. Thus, the distribution of a Rab protein between membranes and the cytoplasm indicates its functional state. GDI overexpression causes preferential release of Rab11 from membranes, possibly because it remains longer than other Rabs in the GDPbound state (27) ; therefore, we investigated the functional state of Rab11. We also looked at Rab5 because it is involved in post-Golgi trafficking and possibly in PrP recycling through clathrin-coated vesicles (38 -41) . Rab5 was equally distributed between the cytosolic and membrane fractions (Fig. 6, A  and B) with no difference in the amount of active, membranebound Rab5 between WT and mutant cells (Fig. 6D ). In contrast, Rab11 was mostly in the cytosol of cells expressing D177N/Met-128 PrP (Fig. 6, A and C) . In these cells, the active, membrane-bound fraction of Rab11 was significantly lower than in WT cells (Fig. 6D) , suggesting that GDI overexpression was associated with reduced Rab11 function.
Expression of D177N/Met-128 PrP Is Associated with Swelling of Golgi Compartment-Reduction in the function
of Rab11 inhibits protein transport to the cell membrane and causes proteins to accumulate in the Golgi (27) . We measured the volume of intracellular organelles in N2a cells expressing WT and D177N/Met-128 PrP. The Golgi volume was significantly increased up to 3.3 times higher in D177N/ Met-128 cells than in WT cells, but no significant differences were found in the ER volume (Fig. 1F) . These data suggested impaired protein trafficking beyond the Golgi network.
Trafficking of GPI-anchored Proteins Is Altered in N2a Cells
Expressing Mutant PrP-To directly test whether post-Golgi trafficking was altered in cells expressing mutant PrP, we investigated the transport of a GFP-GPI reporter. The GFP-GPI lacks identifiable sorting elements other than the C-terminal signal for addition of the GPI anchor, allowing the protein to rapidly cycle between the Golgi and the plasma membrane (28) . A plasmid carrying the GFP-GPI cDNA was transiently transfected in WT and D177N/Met-128 PrP-expressing N2a cells, and the trafficking dynamics of GFP-GPI was measured by counting the fluorescent spots on the cell surface during 1 min by TIRF microscopy. Despite similar GFP-GPI expression as judged by total cellular green fluorescence (data not shown), the amount of GFP-GPI on the plasma membrane was strikingly lower in D177N/Met-128 than in WT cells (Fig. 7, A and B) . This indicated that D177N/ Met-128 PrP expression was associated with impaired postGolgi trafficking of GPI-anchored proteins.
Because PrP is GPI-linked, we also measured the trafficking dynamics of PrP at the cell surface. For this experiment, we transiently transfected N2a cells with WT and D177N/Met-128 PrP-EGFP fusion molecules. TIRF analysis showed a significant impairment of D177N/Met-128 PrP-EGFP trafficking compared with WT PrP-EGFP that was partially rescued when GDI overexpression was knocked down by siRNA ( Fig.  7C and supplemental Fig. 3 ). This result suggested that GDI overexpression in mutant N2a cells stimulates a feedback loop affecting the trafficking of PrP itself. 
DISCUSSION
The cellular pathways activated by mutant PrP ultimately leading to neuronal dysfunction and degeneration in genetic prion diseases are poorly understood. In different non-neuronal and neuronal cells, several mutant PrPs aggregate in the early steps of the secretory pathway, reside longer in the ER and Golgi, and are delivered less efficiently to the cell surface (10, (13) (14) (15) . This held true for D177N/Met-128 PrP expressed in N2a cells that formed insoluble aggregates and was mainly localized in the ER and Golgi.
We used a proteomics approach to investigate the molecular alterations induced by expression of mutant PrP in N2a cells. We optimized the analysis within two pH ranges to explore proteomic alterations by 2DE with high resolution and sensitivity. The alkaline 2D maps allowed us to analyze a portion of the proteome that is hard to detect in conventional 2DE. For example, several mitochondrial proteins have pI values greater than 6 (42) .
The proteomics analysis detected several protein changes indicative of alterations in different biological processes. Because N2a cells expressing PrP D177N/Met-128 survive normally in culture, these protein changes are not due to degenerative events but can be directly ascribed to expression of the mutant PrP. The most affected proteins were associated with energy metabolism, redox regulation, and protein transport (Fig. 4) . Low expression of mitochondrial proteins involved in ATP synthesis is consistent with reduced ATP levels in N2a cells expressing D177N/Met-128 PrP (data not shown) and may indicate a reduction in energy metabolism. This alteration can be expected because cell lines are able to adapt their metabolism in response to cytotoxic insults (43) . Low ATP levels, in fact, may allow mutant N2a to survive longer because high ATP is necessary for apoptosis (44) . Proteins involved in redox regulation, including peroxiredoxin 4, which is implicated in cellular protection against oxidative stress (45) , were up-regulated in the mutant cells. Peroxiredoxins also increased in a transgenic mouse model of inherited prion disease (30) and in prion-infected mice (46) and may be regarded as a cellular response to oxidative stress induced by various forms of pathogenic PrP (47) .
Many ER-resident proteins involved in redox regulation, stress response, and protein folding were also up-regulated in mutant N2a cells, consistent with evidence of altered ER homeostasis in prion diseases (15, 48, 49) . We found upregulation of ERp57, an ER-associated chaperone with protein-disulfide isomerase-like activity. In N2a cells, inhibition of ERp57 enhanced PrP-induced toxicity, whereas overexpression was protective and correlated with a lower rate of caspase-12 activation (49). This suggests that N2a cells expressing D177N/Met-128 PrP can activate cellular responses that counteract PrP toxicity.
One of the proteins that changed most was GDI, an important regulator of Rab proteins, which govern intracellular vesicular trafficking. GDI is believed to interact differently with several Rabs depending on their binding constants and on the time they spend in the GDP-bound state (50, 51) . We found that the amount of cytosolic Rab11, but not Rab5, increased in cells expressing D177N/Met-128 PrP, indicating a selective effect of GDI overexpression on Rab11 localization and function, consistent with previous findings (27) . Reduced Rab11 function impairs delivery of proteins, such as rhodopsin, protease-activated receptor 2, and E-cadherin, to the cell surface with deleterious consequence for cells (52) (53) (54) . Mutant PrP expression was also associated with enlargement of the Golgi, leading us to investigate the functionality of post-Golgi transport. We analyzed by TIRF microscopy the trafficking of a GFP-GPI reporter, which recycles between the plasma membrane and the Golgi complex (28) . We found defective cell membrane delivery of the reporter in N2a cells expressing D177N/Met-128 PrP, confirming a possible link between mutant PrP and dysregulation of post-Golgi transport. Furthermore, we observed that the alteration of mutant PrP trafficking at the cell surface was partially rescued by partially silencing GDI, indicating that alteration of the GDI/Rab11 pathway stimulated a feedback loop leading to further intracellular accumulation of mutant PrP. Intriguingly, it has been shown recently that PrP knockdown in zebrafish embryos causes loss of cell adhesion due to accumulation of E-cadherin in a Rab11-positive post-Golgi compartment (55) . This was associated with activation of Src-related kinases, suggesting that zebrafish PrP may serve a signaling function that regulates post-Golgi trafficking (56). PrP-dependent activation of the tyrosine kinase Fyn has been described in mammalian cells (57) . It is therefore tempting to speculate that PrP may fulfill a conserved signaling function involved in regulating intracellular protein trafficking and that this function may be altered by the pathogenic mutations. Studies are now necessary to determine whether an altered level of GDI can affect the trafficking of other proteins besides the GFP-GPI reporter and D177N/Met-128 PrP and to dissect the underlying mechanism.
In conclusion, our proteomics screening revealed a general up-regulation of the proteins involved in response to cellular insults, such as oxidative and ER stresses. This and the effects on energy metabolism indicated by changes in proteins involved in ATP synthesis may contribute to the survival of mutant PrP cells in culture. Initial studies aimed at defining the cellular processes affected by mutant PrP highlighted a potential toxic feedback involving overexpression of GDI and sequestration of Rab11 in the cytosol, which could lead to alterations of protein trafficking between the Golgi and the plasma membrane and induce further accumulation of mutant PrP (Fig. 8) . Impairment of protein transport could have adverse cellular effects by preventing correct delivery to the plasma membrane of adhesion molecules, ion channels, or receptors important for normal neuronal function. Further studies are now needed to evaluate the role of defective protein trafficking in the pathogenesis of inherited prion diseases.
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